Abstract

Dermatomyositis (DM) represents an idiopathic inflammatory disorder with distinctive skin and muscle involvement. NXP2 (Nuclear Matrix Protein) antibodies positivity defines an uncommon subgroup of patients, with variable clinical outcomes.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call